우리나라 전립샘비대증 유병률: 국민건강보험공단자료를 이용하여
The Prevalence of Benign Prostate Hyperplasia in Korea: Using National Health Insurance Service Data
1
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Objectives: To provide evidences for effective management and prevention of benign prostate hyperplasia (BPH) by analyzing the status of the prevalence of BPH in Korea. Methods: This study was conducted on patients diagnosed with BPH from the claim data of the Korean National Health Insurance Service between 2012 and 2016. We calculated the age-standardization prevalence of patients with BPH and conducted comparative analysis by region and year. Results: The prevalence of age-standardization was 10,847.09 per 100,000 population in 2012 (95% CI, 10,828.72-10,865.47) and 23,552.31 in 2016 (95% CI, 23,526.70-23,577.92). According to comparative analysis by administrative districts, the cumulative prevalence was the highest at in Daejeon (26,076.23, 95% CI, 25,912.82-26,239.64) and the lowest in Ulsan (20,966.97, 95% CI, 20,795.85-21,138.08) in 2016. Also, the proportion of patients who did not visit continuously was 23.5% in 2013 and 37.1% in 2016. Conclusions: The prevalence of BPH increased by 46% in 2016 compared to 2012, and the prevalence increased with age. Therefore, in order to prevent BPH related health problem, it is necessary to develop a systematic management and preventive policy for a super-aged society.
Abstract
Objectives: To provide evidences for effective management and prevention of benign prostate hyperplasia (BPH) by analyzing the status of the prevalence of BPH in Korea. Methods: This study was conducted on patients diagnosed with BPH from the claim data of the Korean National Health Insurance Service between 2012 and 2016. We calculated the age-standardization prevalence of patients with BPH and conducted comparative analysis by region and year. Results: The prevalence of age-standardization was 10,847.09 per 100,000 population in 2012 (95% CI, 10,828.72-10,865.47) and 23,552.31 in 2016 (95% CI, 23,526.70-23,577.92). According to comparative analysis by administrative districts, the cumulative prevalence was the highest at in Daejeon (26,076.23, 95% CI, 25,912.82-26,239.64) and the lowest in Ulsan (20,966.97, 95% CI, 20,795.85-21,138.08) in 2016. Also, the proportion of patients who did not visit continuously was 23.5% in 2013 and 37.1% in 2016. Conclusions: The prevalence of BPH increased by 46% in 2016 compared to 2012, and the prevalence increased with age. Therefore, in order to prevent BPH related health problem, it is necessary to develop a systematic management and preventive policy for a super-aged society.
참고문헌 (19)
- 석윤희, "일개 상급전문종합병원 전립샘비대증 환자들의 삶의 질 영향 요인", 임상간호연구, 23(3), pp.332~340 (2017), 병원간호사회[DOI]
- Kim KH, "Global marketing analysis of benign prostatic hyperplasia", KHIDI Brief, 247, pp.1~8 (2017)
- 이정구, "남성하부요로증상의 병인", Investigative and Clinical Urology, 46(9), pp.887~896 (2005), 대한비뇨의학회
- Djavan B, "An algorithm for medical management in male lower urinary tract symptoms", N Engl J Med, 21, pp.5~12 (2011)
- Naslund MJ, "Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting", Int J Clin Pract, 61, pp.1437~1445 (2007)
- Carrero-Lopez VM, "Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence", Actas Urolo'gicas Espanolas, 40(5), pp.288~294 (2016)
- 김정선, "전립선비대증환자의 건강 관련 삶의 질 영향 요인", Journal of Korean Academy of Nursing, 40(2), pp.287~297 (2010), 한국간호과학회
- 송미경, "사회심리적 스트레스와 전립선 비대증의 연관성 연구", 한국웰니스학회지, 12(1), pp.545~552 (2017), 한국웰니스학회[DOI]
- 고혁준, "Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area", Investigative and Clinical Urology, 56(1), pp.68~75 (2015), 대한비뇨의학회
- 김은정, "전립선비대증에 영향을 미치는 식생활 및 생활습관 요인", Journal of Nutrition and Health, 40(3), pp.249~258 (2007), 한국영양학회
- 박형근, "한국 노령층의 전립선비대증 유병률: 지역기반 연구", Investigative and Clinical Urology, 50(9), pp.843~847 (2009), 대한비뇨의학회
- "Korean Srarisrical Information Service"[URL]
- Kim BS, "A analysis of prevalence of nocturia in males participating in a prostate examination tour", pp.2008
- Wei JT, "Urologic diseases in America project: benign prostatic hyperplasia", J Urol, 173(4), pp.1256~1261 (2005)
- Garraway WM, "High precalenve of benign prostatic hypertrophy in the community", Lancet, 338, pp.469~471 (1991)
- Bosch JL, "The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume", Br J Urol, 75, pp.622~630 (1995)
- 손환철, "Rapid Increase of Health Care Utilization and Cost due to Benign Prostatic Hyperplasia in Korean Men: Retrospective Populationbased Analysis Using the Health Insurance Review and Assessment Service Data", Journal of Korean Medical Science, 30(2), pp.180~185 (2015), 대한의학회
- Kang JY, "National-wide data on the treatment of BPH in Korea", Prostate Cancer Prostatic Dis, 14, pp.243~247 (2011)
- The Korean Prostate Society, "Guidelines for the treatment of prostatic hyperplasia in Korea", pp.75~76 (2010)